Skip to main content
Premium Trial:

Request an Annual Quote

GenomSys Raises CHF 9.3M in Series A Round

NEW YORK – GenomSys, a startup maker of DNA data processing software based in Switzerland, said today that it has closed a CHF 9.3 million ($9.3 million) Series A investment round. 

Geneva-based Preon Capital led the round, with participation from several European and American partners, including Elysia Capital, Dolby Family Ventures, and Susman Ventures. As a result of the investment, Dolby Family Ventures Managing Director Pascal Levensohn has joined the GenomSys board of directors.

GenomSys, founded in 2016 and headquartered in Lausanne, makes genomic analysis software based on the recently finalized MPEG-G data compression standard. Among other things, MPEG-G promises to give individuals access to genomic data and other aspects of personalized medicine on mobile devices, the company said.

The GenomSys software "will bring a dramatic reduction in genomic files' size, a faster information transfer, and more efficient data analysis," Cofounder Claudio Alberti said in a statement.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.